We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-15.9%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$314B
AUM Growth
-$33.1B
Cap. Flow
+$31.5B
Cap. Flow %
10.02%
Top 10 Hldgs %
30.1%
Holding
11,456
New
1,843
Increased
4,539
Reduced
3,686
Closed
1,300

Sector Composition

Rank Sector Weight
1 Technology 2.01%
2 Communication Services 1.39%
3 Financials 0.98%
4 Consumer Discretionary 0.94%
5 Healthcare 0.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWI icon
9876
CALL
Titan International
TWI
$464M
$21K ﹤0.01%
+13,500
New +$34.6K
CMRX
9877
DELISTED
Chimerix, Inc.
CMRX
$21K ﹤0.01%
14,282
-30,954
-68% -$54.2K
TRVN
9878
DELISTED
Trevena, Inc.
TRVN
$21K ﹤0.01%
61
+9
+17% +$4.31K
CSLT
9879
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$21K ﹤0.01%
28,675
+13,063
+84% +$14.6K
GEN
9880
DELISTED
Genesis Healthcare, Inc.
GEN
$21K ﹤0.01%
+24,960
New +$35.7K
NBRV
9881
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$21K ﹤0.01%
149
-514
-78% -$157K
AFH
9882
DELISTED
Atlas Financial Holdings, Inc. Ordinary Shares
AFH
$21K ﹤0.01%
65,696
-15,647
-19% -$8.13K
DNR
9883
PUT
DELISTED
Denbury Resources, Inc.
DNR
$21K ﹤0.01%
112,900
-162,300
-59% -$136K
IO
9884
DELISTED
ION Geophysical Corporation
IO
$21K ﹤0.01%
+16,453
New +$71K
CLDX icon
9885
CALL
Celldex Therapeutics
CLDX
$3.24B
$20K ﹤0.01%
11,900
+1,300
+12% +$2.94K
EQS icon
9886
Equus Total Return
EQS
$14.5M
$20K ﹤0.01%
20,845
-93
-0.4% -$144
INDP icon
9887
Indaptus Therapeutics
INDP
$145M
$20K ﹤0.01%
48
+40
+500% +$30.2K
STGW icon
9888
CALL
Stagwell
STGW
$2.13B
$20K ﹤0.01%
13,500
-7,900
-37% -$17.3K
VRDN icon
9889
Viridian Therapeutics
VRDN
$2.74B
$20K ﹤0.01%
+3,014
New +$35.1K
NTRP
9890
PUT
DELISTED
Neurotrope, Inc. Common
NTRP
$20K ﹤0.01%
24,200
-2,000
-8% -$2.18K
VRML
9891
DELISTED
Vermillion, Inc.
VRML
$20K ﹤0.01%
+24,043
New +$19.4K
BHR
9892
PUT
Braemar Hotels & Resorts
BHR
$141M
$19K ﹤0.01%
+11,000
New +$72.9K
PRPO icon
9893
Precipio
PRPO
$55.2M
$19K ﹤0.01%
+1,333
New +$41.7K
TRVG
9894
trivago
TRVG
$389M
$19K ﹤0.01%
2,660
-2,025
-43% -$23K
VXRT
9895
DELISTED
Vaxart
VXRT
$19K ﹤0.01%
+10,742
New +$13.7K
DSKE
9896
DELISTED
Daseke, Inc. Common Stock
DSKE
$19K ﹤0.01%
+13,818
New +$40.7K
RRD
9897
DELISTED
RR Donnelley & Sons Co.
RRD
$19K ﹤0.01%
19,658
-269,826
-93% -$653K
SBBP
9898
DELISTED
Strongbridge Biopharma plc.
SBBP
$19K ﹤0.01%
10,223
-5,095
-33% -$13.2K
RLH
9899
PUT
DELISTED
Red Lions Hotel Corporation
RLH
$19K ﹤0.01%
12,800
+2,800
+28% +$7.49K
AKRX
9900
DELISTED
Akorn Inc
AKRX
$19K ﹤0.01%
+33,421
New +$38.7K

Similar funds

Jeff Yass's Q1 2020 Portfolio in Review

As of Q1 2020, Jeff Yass held 11,456 positions worth $314B, down 9.5% from $347B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jeff Yass deployed $31.5B of net new capital in Q1 2020, opening 1,843 new positions and adding to 4,539 existing holdings. Its largest new stake was Invesco DB US Dollar Index Bullish Fund: 8,692,802 shares worth $233M.

By sector, the portfolio is most concentrated in Technology at 2% of assets, down from 2.2% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was Amazon, an estimated $946M trimmed.

  • Jeff Yass's largest Q1 2020 buy was Invesco DB US Dollar Index Bullish Fund: 8,692,802 shares worth $233M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $6.39B increase.
  • Jeff Yass's biggest Q1 2020 reduction was Amazon, cutting an estimated $946M.
  • Jeff Yass fully exited Medicines Co in Q1 2020, selling an estimated $92M.
  • Jeff Yass's ten largest holdings make up 30% of its $314B portfolio in Q1 2020.
  • Jeff Yass opened 1,843 new positions and closed 1,300 in Q1 2020.
  • Jeff Yass's portfolio value fell 9.5% quarter-over-quarter to $314B.

Based on Susquehanna International Group's 13F filing for Q1 2020, filed 15 May 2020.